Response to Comments: Tumor Treatment Field Therapy (TTFT) - DL34823

This response-to-comments excerpt indicates Tumor Treatment Field Therapy (TTFT) is intended for Medicare-eligible beneficiaries with newly diagnosed glioblastoma multiforme and that coverage decisions will rely on the best available published clinical evidence. Adjudication follows CMS Program Integrity Manual Chapter 13 standards requiring general acceptance in the medical community, but the excerpt does not provide specific procedural, documentation, frequency, ICD-10, or prior-authorization details and requires review of the final LCD for complete criteria.

"Tumor Treatment Field Therapy (TTFT, e."

Sign up to see full coverage criteria, indications, and limitations.